20
Views
5
CrossRef citations to date
0
Altmetric
Research Article

The Treatment of Acute Anxiety States in Neurotic Patients with Intravenous Lorazepam. A Placebo-Controlled Study

, M.D.
Pages 16-21 | Received 18 Nov 1974, Published online: 05 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

R. Deberdt. (1975) Treatment of Acute Anxiety and Agitation by Intravenous Administration of Lorazepam. Current Medical Research and Opinion 3:7, pages 459-463.
Read now
A. B. Khorana. (1975) Intravenous Lorazepam in Acute Anxiety States. Current Medical Research and Opinion 3:7, pages 453-458.
Read now

Articles from other publishers (3)

Aurel C. Cernaianu, Anthony J. DelRossi, David R. Flum, Teimouraz V. Vassilidze, Steven E. Ross, Jr Cilley, Michael A. Grosso & Philip G. Boysen. (1996) Lorazepam and midazolam in the intensive care unit. Critical Care Medicine 24:2, pages 222-228.
Crossref
Pedro Gómez-Lozano. (2016) Management of Acute Anxiety Syndrome with Parenterally Administered Lorazepam. Journal of International Medical Research 6:3, pages 186-192.
Crossref
DAVID J. GREENBLATT, WALTER H. COMER, HENRY W. ELLIOTT, RICHARD I. SHADER, JOHN A. KNOWLES & HANS W. RUELIUS. (1977) Clinical Pharmacokinetics of Lorazepam. III. Intravenous Injection. Preliminary Results. The Journal of Clinical Pharmacology 17:8-9, pages 490-494.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.